|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
7
|
|
pubmed:dateCreated |
2009-7-14
|
|
pubmed:abstractText |
The therapeutic effects of oral capecitabine are proposed to be determined by the equilibrium of two intratumoral metabolizing enzymes, namely thymidine phosphorylase (TP) and dihydropyrimidine dehydrogenase (DPD). The present study aims to evaluate this hypothesis by in vivo experiments and immunohistochemical analysis in 31 cases of human breast carcinoma.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
1791-7530
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
29
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
2525-30
|
|
pubmed:meshHeading |
pubmed-meshheading:19596923-Antineoplastic Agents,
pubmed-meshheading:19596923-Breast Neoplasms,
pubmed-meshheading:19596923-Carcinoma, Ductal, Breast,
pubmed-meshheading:19596923-Cell Line, Tumor,
pubmed-meshheading:19596923-Cell Proliferation,
pubmed-meshheading:19596923-Deoxycytidine,
pubmed-meshheading:19596923-Dihydrouracil Dehydrogenase (NADP),
pubmed-meshheading:19596923-Female,
pubmed-meshheading:19596923-Fluorouracil,
pubmed-meshheading:19596923-Humans,
pubmed-meshheading:19596923-Immunohistochemistry,
pubmed-meshheading:19596923-In Situ Nick-End Labeling,
pubmed-meshheading:19596923-Middle Aged,
pubmed-meshheading:19596923-RNA, Messenger,
pubmed-meshheading:19596923-Thymidine Phosphorylase
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Expression of thymidine phosphorylase and dihydropyrimidine dehydrogenase in human breast carcinoma cells and tissues.
|
|
pubmed:affiliation |
Department of Pathology, Tohoku University Graduate School of Medicine, Sendai, Japan. tyloo@hku.hk
|
|
pubmed:publicationType |
Journal Article
|
